Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Plos One|January 7, 2014
Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drugCecilia Garofalo, Mariantonietta Capristo, Maria Cristina Manara, et al.
International Journal of Oncology|December 12, 2012
miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle controlChiara Novello, Laura Pazzaglia, Chiara Cingolani, et al.
Oncology Reports|May 13, 2004
Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cellsTokuhiro Chano, Kanji Mori, Katia Scotlandi, et al.
Oncogene|April 13, 2005
In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell typeStefania Benini, Bernard Perbal, Diana Zambelli, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2005
4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patientsMichela Pasello, Claudia Maria Hattinger, Giuseppina Stoico, et al.
Oxidative Medicine and Cellular Longevity|January 5, 2019
Oxidative Stress in Autistic Children Alters Erythrocyte Shape in the Absence of Quantitative Protein Alterations and of Loss of Membrane Phospholipid AsymmetryAlessandra Bolotta, Michela Battistelli, Elisabetta Falcieri, et al.
Cancer Letters|November 23, 2006
Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cellsMaria Serena Benassi, Antonella Chiechi, Francesca Ponticelli, et al.
International Journal of Oncology|November 8, 2006
May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocolMassimo Serra, Michela Pasello, Maria Cristina Manara, et al.
Journal of Cell Communication and Signaling|November 11, 2024
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscapeMichela Pasello, Maria Antonella Laginestra, Maria Cristina Manara, et al.
Pageof 8